Target intelligence / Profile preview

Parvin beta (PARVB)

Target
PARVB
Molecular classification
Other (Actin-binding protein), Cytoskeletal protein, Adaptor protein
01

Overview

Parvin beta (PARVB) is an actin-binding adaptor protein of the parvin family, found at focal adhesions within the cytoplasm where it interacts with integrin-linked kinase (ILK), paxillin, alpha-actinin, and guanine nucleotide exchange factors. It plays a central role in coordinating integrin signaling, reorganizing the actin cytoskeleton, mediating cell adhesion and migration, regulating anchorage, and establishing cell polarity[1][2][5]. PARVB is also implicated in tumor suppression, with its downregulation enhancing oncogenic signaling and promoting tumor progression and metastasis in several carcinomas[1]. It is genetically associated with metabolic liver disease (notably nonalcoholic fatty liver disease) and participates in membrane repair in muscle and in response to bacterial effector proteins, highlighting roles beyond structural cytoskeletal support[1]. PARVB is not considered a typical drug target or receptor and currently has no known direct therapeutic ligands or drugs[1][2][5].

Other names
Beta-parvinAffixinCGI-56PARVB
02

Biological functions

Cytoskeleton organizationCell adhesionFocal adhesion assemblyRegulation of cell morphologyCell migrationTumor suppressionSignal transduction (via integrin signaling)
03

Disease associations

Cancer (tumor suppression; implicated in breast, colorectal, ovarian, urothelial cancer progression when downregulated)Metabolic diseases (associated with nonalcoholic fatty liver disease via genetic studies)Muscle disease (involved in membrane repair in skeletal muscle)Infection (modulated during Legionella pneumophila infection)

Beyond the preview

Go deeper on Parvin beta (PARVB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parvin beta (PARVB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call